SERUM INSTITUTE OF INDIA PVT LTD

Serum Institute of India Pvt Ltd Company Introduction:

Serum Institute of India Pvt Ltd (SII) is an Indian biotechnology and biopharmaceutical company. It was founded in 1966 by Cyrus Poonawalla and is headquartered in Pune, India. SII is globally recognized as the world's largest vaccine manufacturer by number of doses produced and sold, manufacturing over 1.5 billion doses annually. The company's primary mission is to produce highly affordable vaccines for the global population, with a significant focus on serving developing countries. SII develops and manufactures a wide range of vaccines for various diseases, including measles, mumps, rubella, polio, tetanus, diphtheria, pertussis, Hib, hepatitis B, and influenza, among others. In recent times, it has played a crucial role in the global fight against the COVID-19 pandemic by producing large quantities of COVID-19 vaccines.

Factory or Trader:

Serum Institute of India Pvt Ltd is a manufacturer (factory).

The Serum Institute of India Pvt Ltd manufactures or sells the following products:

COVID-19 Vaccines

Pneumococcal Conjugate Vaccine (PCV)

Rotavirus Vaccine

Measles, Mumps, Rubella (MMR) Vaccine

Diphtheria, Tetanus, Pertussis (DTwP) Vaccines

Diphtheria, Tetanus, acellular Pertussis (DTaP) Vaccines

Tetanus Toxoid (TT) Vaccine

Hepatitis B Vaccine

Human Papillomavirus (HPV) Vaccine

Oral Polio Vaccine (OPV)

Inactivated Polio Vaccine (IPV)

Rabies Vaccine

Influenza Vaccine

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Typhoid Conjugate Vaccine

Varicella (Chickenpox) Vaccine

Rubella Vaccine

Measles Vaccine

Diphtheria and Tetanus (DT) Vaccine